L Pernomian1, Ms Gomes, Am de Oliveira. 1. Department of Pharmacology, School of Medicine of Ribeirão Preto, Laboratory of Pharmacology, University of São Paulo, Brazil.
Abstract
BACKGROUND AND PURPOSE: The consequences of compensatory responses to balloon catheter injury in rat carotid artery, on phenylephrine-induced relaxation and contraction in the contralateral carotid artery were studied. EXPERIMENTAL APPROACH: Relaxation and contraction concentration-response curves for phenylephrine were obtained for contralateral carotid arteries in the presence of indomethacin (COX inhibitor), SC560 (COX-1 inhibitor), SC236 (COX-2 inhibitor) or 4-hydroxytetramethyl-L-piperidine-1-oxyl (tempol; superoxide dismutase mimetic). Reactive oxygen species were measured in carotid artery endothelial cells fluorimetrically with dihydroethidium. KEY RESULTS: Phenylephrine-induced relaxation was abolished in contralateral carotid arteries from operated rats (E(max) = 0.01 ± 0.004 g) in relation to control (E(max) = 0.18 ± 0.005 g). Phenylephrine-induced contractions were increased in contralateral arteries (E(max) = 0.54 ± 0.009 g) in relation to control (E(max) = 0.38 ± 0.014 g). SC236 restored phenylephrine-induced relaxation (E(max) = 0.17 ± 0.004 g) and contraction (E(max) = 0.34 ± 0.018 g) in contralateral arteries. Tempol restored phenylephrine-induced relaxation (E(max) = 0.19 ± 0.012 g) and contraction (E(max) = 0.42 ± 0.014 g) in contralateral arteries, while apocynin did not alter either relaxation (E(max) = 0.01 ± 0.004 g) or contraction (E(max) = 0.54 ± 0.009 g). Dihydroethidium fluorescence was increased in contralateral samples (18 882 ± 435 U) in relation to control (10 455 ± 303 U). SC236 reduced the fluorescence in contralateral samples (8250 ± 365 U). CONCLUSIONS AND IMPLICATIONS: Balloon catheter injury abolished phenylephrine-induced relaxation and increased phenylephrine-induced contraction in contralateral carotid arteries, through O(2) (-) derived from COX-2.
BACKGROUND AND PURPOSE: The consequences of compensatory responses to balloon catheter injury in rat carotid artery, on phenylephrine-induced relaxation and contraction in the contralateral carotid artery were studied. EXPERIMENTAL APPROACH: Relaxation and contraction concentration-response curves for phenylephrine were obtained for contralateral carotid arteries in the presence of indomethacin (COX inhibitor), SC560 (COX-1 inhibitor), SC236 (COX-2 inhibitor) or 4-hydroxytetramethyl-L-piperidine-1-oxyl (tempol; superoxide dismutase mimetic). Reactive oxygen species were measured in carotid artery endothelial cells fluorimetrically with dihydroethidium. KEY RESULTS:Phenylephrine-induced relaxation was abolished in contralateral carotid arteries from operated rats (E(max) = 0.01 ± 0.004 g) in relation to control (E(max) = 0.18 ± 0.005 g). Phenylephrine-induced contractions were increased in contralateral arteries (E(max) = 0.54 ± 0.009 g) in relation to control (E(max) = 0.38 ± 0.014 g). SC236 restored phenylephrine-induced relaxation (E(max) = 0.17 ± 0.004 g) and contraction (E(max) = 0.34 ± 0.018 g) in contralateral arteries. Tempol restored phenylephrine-induced relaxation (E(max) = 0.19 ± 0.012 g) and contraction (E(max) = 0.42 ± 0.014 g) in contralateral arteries, while apocynin did not alter either relaxation (E(max) = 0.01 ± 0.004 g) or contraction (E(max) = 0.54 ± 0.009 g). Dihydroethidium fluorescence was increased in contralateral samples (18 882 ± 435 U) in relation to control (10 455 ± 303 U). SC236 reduced the fluorescence in contralateral samples (8250 ± 365 U). CONCLUSIONS AND IMPLICATIONS: Balloon catheter injury abolished phenylephrine-induced relaxation and increased phenylephrine-induced contraction in contralateral carotid arteries, through O(2) (-) derived from COX-2.
Authors: David K Johnson; Kurt J Schillinger; David M Kwait; Chambers V Hughes; Erin J McNamara; Fauod Ishmael; Robert W O'Donnell; Ming-Mei Chang; Michael G Hogg; Jonathan S Dordick; Lakshmi Santhanam; Linda M Ziegler; James A Holland Journal: Endothelium Date: 2002
Authors: T Matoba; H Shimokawa; M Nakashima; Y Hirakawa; Y Mukai; K Hirano; H Kanaide; A Takeshita Journal: J Clin Invest Date: 2000-12 Impact factor: 14.808
Authors: Jie-Sheng Zheng; Xiang-Qun Yang; Keith J Lookingland; Gregory D Fink; Christian Hesslinger; Gregory Kapatos; Imre Kovesdi; Alex F Chen Journal: Circulation Date: 2003-08-18 Impact factor: 29.690
Authors: Rhian M Touyz; Xin Chen; Fatiha Tabet; Guoying Yao; Gang He; Mark T Quinn; Patrick J Pagano; Ernesto L Schiffrin Journal: Circ Res Date: 2002-06-14 Impact factor: 17.367
Authors: Larissa Pernomian; Lilian R Gimenes; Mayara S Gomes; Bruno N do Vale; Cristina R B Cardoso; Ana M de Oliveira; Josimar D Moreira Journal: Biomed Res Int Date: 2017-09-14 Impact factor: 3.411
Authors: Nathalia Juocys Dias Moreira; Fernando Dos Santos; Edson Dias Moreira; Daniela Farah; Leandro Eziquiel de Souza; Maikon Barbosa da Silva; Ivana Cinthya Moraes-Silva; Gisele Silvério Lincevicius; Elia Garcia Caldini; Maria Cláudia Costa Irigoyen Journal: Sci Rep Date: 2020-12-11 Impact factor: 4.379
Authors: Larissa Pernomian; Mayara Santos Gomes; Carolina Baraldi Araujo Restini; Ana Maria de Oliveira Journal: Biomed Res Int Date: 2014-04-29 Impact factor: 3.411